Table 2. Effects of chitosan oligosaccharide supplementation on the amniotic fluid immune responses of sowsa.
Items | Treatmentsb |
P-value | |
---|---|---|---|
CON | COS | ||
IL-1c (pg/mL) | 163.33 ± 20.82 | 190.06 ± 49.46 | 0.250 |
IL-6d (pg/mL) | 34.19 ± 6.46 | 30.79 ± 5.36 | 0.345 |
IL-10e (pg/mL) | 109.67 ± 10.33 | 136.42 ± 15.36** | 0.005 |
TNF-αf (pg/mL) | 142.36 ± 22.36 | 155.72 ± 15.78 | 0.259 |
IgGg (μg/mL) | 92.75 ± 21.92 | 152.17 ± 8.82** | <0.001 |
IgAh (μg/mL) | 64.23 ± 9.03 | 70.83 ± 10.40 | 0.268 |
IgMi (μg/mL) | 76.26 ± 19.60 | 98.94 ± 12.98* | 0.040 |
*P < 0.05 versus the CON group. **P < 0.01 versus the CON group.
aValues are means of six replications per treatment.
bCON: A corn-soybean basal diet; COS: Chitosan oligosaccharide (the basal diet supplemented with 100 mg/kg chitosan oligosaccharide).
cIL-1: Interleukin 1.
dIL-6, Interleukin 6.
eIL-10: Interleukin 10.
fTNF-α: Tumour necrosis factor α.
gIgG: Immunoglobulin G.
gIgA: Immunoglobulin A.
iIgM: Immunoglobulin M.